JACOBS LEVY EQUITY MANAGEMENT, INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 160 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$3,576,000
+13.6%
198,772
+12.0%
0.05%
+48.4%
Q4 2019$3,147,000
-58.5%
177,522
-63.7%
0.03%
-66.7%
Q3 2019$7,584,000
-16.6%
489,002
-7.7%
0.09%
-26.2%
Q2 2019$9,098,000
+22.5%
529,598
+14.8%
0.13%
+17.8%
Q1 2019$7,425,000
+55.0%
461,178
+40.8%
0.11%
+27.4%
Q4 2018$4,791,000
-24.9%
327,478
-6.7%
0.08%
-6.7%
Q3 2018$6,377,000
+20.9%
350,978
+12.3%
0.09%
+8.4%
Q2 2018$5,274,000
+5.7%
312,630
+22.7%
0.08%0.0%
Q1 2018$4,990,000
+241.5%
254,740
+253.3%
0.08%
+219.2%
Q4 2017$1,461,000
+131.5%
72,110
+98.6%
0.03%
+116.7%
Q3 2017$631,000
+31.7%
36,310
-25.1%
0.01%
+33.3%
Q4 2016$479,000
+190.3%
48,482
+153.8%
0.01%
+200.0%
Q2 2016$165,000
-6.2%
19,100
+2.7%
0.00%
-25.0%
Q1 2016$176,000
+2.9%
18,600
+46.5%
0.00%0.0%
Q3 2015$171,000
-47.7%
12,700
-12.4%
0.00%
-33.3%
Q2 2015$327,00014,5000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders